Founder
Founder
Genixus develops targeted pharmaceutical formulations for acute and critical care, focusing on enhancing the efficacy and safety of life-saving medications. The company addresses the urgent need for improved treatment options in high-stakes medical environments, ensuring better patient outcomes and streamlined care processes.
Raised to date
$20MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founder